Labelling of human serum albumin (HSA)-nanospheres with technetium-99m radionuclide
Labelling of HSA-nanospheres with technetium-99m was carried out by direct and indirect method using sodium pyrophosphate as co-ligand agent. The labelling efficiency was determined by several chromatography system for separation of 99mTc-HSA-nanospheres labelled compound from its radiochemical impurities. Several parameters influencing the labelling process were studied such as pH, kinds and quantity of reductor agent, labelling method, quantity of HSA-nanospheres and temperature and the duration of incubation. The result show that the optimum direct labelling condition was found by using 0.5 mL HSA-nanospheres solution (which had absorbance of 0.6 at l= 202 nm), 100-150 μg of SnCl2.2H2O as reductor, pH mixture was 2 and the first incubation was done at room temperature for 25 minutes. The labelling process was continued by adding technetium-99m of certain activity, and finally pH was adjusted to 5.5-6.0. The second incubation was carried out at room temperature for 15 minutes. This direct method resulted more than 90% of labelling efficiency, with free 99mTc-pertechnetate as radiochemical impurity. The indirect labelling process by using 0.5 mL of HSA-nanospheres solution, 100 μg of SnCl2.2H2O was prior reacted with 1.0 mg of sodium pyrophosphate (1 : 5 mol/mol), the pH was adjusted to 7.4 and incubation was done in the incubator at 37oC for 15 minutes. After adding 99mTc-pertechnetate solution, the second incubation was done at room temperature for 15 minutes. This indirect labelling resulted 93.4 ± 1.2 % of labelling efficiency with remain of 99mTc-pertechnetat and 99mTc-pyrophosphate as radiochemical impurities.
Key words: lymphoscintigraphy, nanocolloid, technetium-99m, radiochemical impurities.
Dillehay, G. L. Henkin R. E. et.al, 2006, Lymphoscintigraphy in oncology , Nuclear Medicine, 2nd ed. Mosby Elsevier Inc., Philadelphia, 1480-1481.
Gopal B. S., 2004, Fundamental of Nuclear Pharmacy. Miscellaneous Imaging Procedures, 5th ed., Springer, USA, 319.
Kaplan W. D., Davis, M. A., and Rose C. M., 1979, A Comparasion of Two Technetium-99m-Labelled Radiopharmaceuticals for Lymphoscintigraphy. J.Nucl.Med., 20, 933-937.
Khopkar S. M., 1990, Konsep Dasar Kimia Analitik, terjemahan Saptorahardjo A. Ed.1, UI-Press, Indonesia, 219. Lymphatic filariasis. Strategy direction for lymphatic filariasis research. [serial on-line] 2002, Feb; 1: http://www.who.int/tdr/diseases/lymphfil/direction.htm
Owunwanne, A., Patel M, and Sadek S., 1995, The hand book of radiopharmaceuticals. 1st ed., Chapman and Hall Medical Clays Ltd., England , 67-68.
Setiawan E., Sukanta, Kartini N., and Nurlaila Z., 1987, Peranan Senyawa Pirofosfat pada Penandaan Sel Darah Merah dengan Teknesium-99m Secara In-vivo. Skripsi Sarjana (S1), Fakultas Matematika dan Ilmu Pengetahuan Alam, UNPAD, Bandung, 72-73.
Zolle, I., 2007, Technetium-99m pharmaceuticals, 99mTc-Labelled Colloids, 1st ed. Springer, Berlin, Heidelberg, 230-235.
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by:View My Stats